Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Queensland Health
Harvard Business School
Boehringer Ingelheim
Merck

Generated: March 22, 2019

DrugPatentWatch Database Preview

Litigation for RAVICTI

« Back to Dashboard

US Court Litigation for RAVICTI

Patent Trial and Appeal Board Cases for RAVICTI

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,404,215 Par Pharmaceutical, Inc. ➤ Try a Free Trial 2015-04-29 2015-04-29 Horizon Therapeutics, Inc. Inter partes review ➤ Try a Free Trial 2015-11-04 Bruce SCHARSCHMIDT ➤ Try a Free Trial
8,404,215 Lupin Pharmaceuticals, Inc. ➤ Try a Free Trial 2015-12-04 2015-12-04 Horizon Therapeutics, Inc. Inter partes review ➤ Try a Free Trial 2016-06-08 Bruce SCHARSCHMIDT ➤ Try a Free Trial
8,642,012 Par Pharmaceutical, Inc. ➤ Try a Free Trial 2015-04-29 2015-04-29 Horizon Therapeutics, Inc. Inter partes review ➤ Try a Free Trial 2015-11-04 Bruce SCHARSCHMIDT ➤ Try a Free Trial
8,642,012 Lupin Pharmaceuticals, Inc. ➤ Try a Free Trial 2015-12-04 2015-12-04 Horizon Therapeutics, Inc. Inter partes review ➤ Try a Free Trial 2016-06-08 Bruce SCHARSCHMIDT ➤ Try a Free Trial
9,095,559 Lupin Ltd ➤ Try a Free Trial 2016-04-01 2016-04-01 Scharschmidt et al Inter partes review ➤ Try a Free Trial 2016-09-30 Bruce Scharschmidt ➤ Try a Free Trial
9,095,559 Par Pharmaceutical, Inc. ➤ Try a Free Trial 2017-07-13 2017-07-13 Scharschmidt et al Inter partes review ➤ Try a Free Trial 2018-01-30 ➤ Try a Free Trial
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
QuintilesIMS
Healthtrust
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.